FULC
Fulcrum Therapeutics Inc
3.70$
-1.2%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | |
| – | +88.1% | +52.6% | +15.9% | +5.7% | -4.0% | -10.0% | -26.7% | -12.7% | |
| – | +57.5% | +95.6% | +74.0% | +50.6% | +20.6% | +10.9% | -1.7% | -14.3% | |
| – | +57.5% | +1,281.0% | -75.3% | +50.6% | +20.6% | – | – | – | |
| – | +711.2% | +73.7% | -33.8% | -258.5% | – | – | – | – | |
| – | +370.7% | -90.5% | +57.3% | +27.6% | +14.6% | -74.1% | -45.3% | +12.9% | |
| – | +370.7% | -89.5% | +5,952.8% | +126.9% | – | -395.6% | – | -4.7% | |
| – | – | – | – | – | – | – | – | – | |
| – | +495.0% | -100.0% | +467.6% | – | -105.3% | – | – | – | |
| – | +0.0% | -35.7% | +11.1% | -64.0% | +177.8% | – | – | – | |
| – | +494.6% | -38.7% | +10.6% | +162.2% | -54.8% | +40.1% | -97.7% | +6,042.3% | |
| – | – | -67.5% | -265.8% | – | – | – | – | +325.3% | |
| – | – | – | – | – | – | – | – | – |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.